Infusion of Haploidentical HSCs Combined with Allogenic MSCs for the Treatment of ALL Patients

Investigators designed a combination of haploidentical stem cell (HSC) transplantation and MSCs for acute lymphoblastic leukemia (ALL) patients. ALL patients were given haploidentical HSCs combined with allogenic MSCs, and ALL patients without MSC infusion were included as controls.